87
Views
154
CrossRef citations to date
0
Altmetric
Signal Transduction

Overexpression of Glucose-6-Phosphate Dehydrogenase Is Associated with Lipid Dysregulation and Insulin Resistance in Obesity

, , , , &
Pages 5146-5157 | Received 16 Sep 2004, Accepted 11 Mar 2005, Published online: 27 Mar 2023

REFERENCES

  • Abu-Elheiga, L., M. M. Matzuk, K. A. Abo-Hashema, and S. J. Wakil. 2001. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613–2616.
  • Abu-Elheiga, L., W. Oh, P. Kordari, and S. J. Wakil. 2003. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. USA 100:10207–10212.
  • Arner, P. 2002. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab. Res. Rev. 18(Suppl. 2):S5–S9.
  • Banerjee, R. R., S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. Wang, M. W. Rajala, A. Pocai, P. E. Scherer, C. M. Steppan, R. S. Ahima, S. Obici, L. Rossetti, and M. A. Lazar. 2004. Regulation of fasted blood glucose by resistin. Science 303:1195–1198.
  • Berg, A. H., T. P. Combs, X. Du, M. Brownlee, and P. E. Scherer. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7:947–953.
  • Berg, A. H., T. P. Combs, and P. E. Scherer. 2002. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13:84–89.
  • Berti, L., M. Kellerer, E. Capp, and H. U. Haring. 1997. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect. Diabetologia 40:606–609.
  • Beutler, E., and T. J. Vulliamy. 2002. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol. Dis. 28:93–103.
  • Biagiotti, E., L. Guidi, P. Del Grande, and P. Ninfali. 2003. Glucose-6-phosphate dehydrogenase expression associated with NADPH-dependent reactions in cerebellar neurons. Cerebellum 2:178–183.
  • Boden, G. 2001. Free fatty acids: the link between obesity and insulin resistance. Endocrinol. Pract. 7:44–51.
  • Boden, G. 2002. Interaction between free fatty acids and glucose metabolism. Curr. Opin. Clin. Nutr. Metab. Care. 5:545–549.
  • Boden, G. 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10.
  • Boden, G., and G. I. Shulman. 2002. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Investig. 32(Suppl. 3):14–23.
  • Bray, G. A., and L. A. Tartaglia. 2000. Medicinal strategies in the treatment of obesity. Nature 404:672–677.
  • Dessi, S., B. Batetta, O. Spano, D. Pulisci, M. F. Mulas, S. Muntoni, M. Armeni, C. Sanna, R. Antonucci, and P. Pani. 1992. Serum lipoprotein pattern as modified in G6PD-deficient children during hemolytic anaemia induced by fava bean ingestion. Int. J. Exp. Pathol. 73:157–160.
  • Dessi, S., C. Chiodino, B. Batetta, A. M. Fadda, C. Anchisi, and P. Pani. 1986. Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp. Mol. Pathol. 44:169–176.
  • Fulco, M., R. L. Schiltz, S. Iezzi, M. T. King, P. Zhao, Y. Kashiwaya, E. Hoffman, R. L. Veech, and V. Sartorelli. 2003. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell 12:51–62.
  • Gordon, G. B., J. A. Newitt, L. M. Shantz, D. E. Weng, and P. Talalay. 1986. Inhibition of the conversion of 3T3 fibroblast clones to adipocytes by dehydroepiandrosterone and related anticarcinogenic steroids. Cancer Res. 46:3389–3395.
  • Halle, M., A. Berg, H. Northoff, and J. Keul. 1998. Importance of TNF-alpha and leptin in obesity and insulin resistance: a hypothesis on the impact of physical exercise. Exerc. Immunol. Rev. 4:77–94.
  • Hauner, H. 2002. The mode of action of thiazolidinediones. Diabetes Metab. Res. Rev. 18(Suppl. 2):S10–S15.
  • Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Investig. 109:1125–1131.
  • Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91.
  • Hu, E., P. Liang, and B. M. Spiegelman. 1996. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271:10697–10703.
  • Hu, Z., S. H. Cha, S. Chohnan, and M. D. Lane. 2003. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proc. Natl. Acad. Sci. USA 100:12624–12629.
  • Imai, S., C. M. Armstrong, M. Kaeberlein, and L. Guarente. 2000. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795–800.
  • Jain, R. G., K. D. Phelps, and P. H. Pekala. 1999. Tumor necrosis factor-alpha initiated signal transduction in 3T3-L1 adipocytes. J. Cell Physiol. 179:58–66.
  • Kabashima, T., T. Kawaguchi, B. E. Wadzinski, and K. Uyeda. 2003. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc. Natl. Acad. Sci. USA 100:5107–5112.
  • Kahn, B. B., and J. S. Flier. 2000. Obesity and insulin resistance. J. Clin. Investig. 106:473–481.
  • Kersten, S. 2001. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2:282–286.
  • Kim, J. B., and B. M. Spiegelman. 1996. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 10:1096–1107.
  • Kim, J. B., H. M. Wright, M. Wright, and B. M. Spiegelman. 1998. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA 95:4333–4337.
  • Kim, K. H., K. Lee, Y. S. Moon, and H. S. Sul. 2001. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 276:11252–11256.
  • Kletzien, R. F., P. K. Harris, and L. A. Foellmi. 1994. Glucose-6-phosphate dehydrogenase: a “housekeeping” enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J. 8:174–181.
  • Koh, H. J., S. M. Lee, B. G. Son, S. H. Lee, Z. Y. Ryoo, K. T. Chang, J. W. Park, D. C. Park, B. J. Song, R. L. Veech, H. Song, and T. L. Huh. 2004. Cytosolic NADP+-dependent isocitrate dehydrogenase plays a key role in lipid metabolism. J. Biol. Chem. 279:29968–29974.
  • Kondo, H., I. Shimomura, Y. Matsukawa, M. Kumada, M. Takahashi, M. Matsuda, N. Ouchi, S. Kihara, T. Kawamoto, S. Sumitsuji, T. Funahashi, and Y. Matsuzawa. 2002. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 51:2325–2328.
  • Kopelman, P. G. 2000. Obesity as a medical problem. Nature 404:635–643.
  • Kumar, V., J. E. Carlson, K. A. Ohgi, T. A. Edwards, D. W. Rose, C. R. Escalante, M. G. Rosenfeld, and A. K. Aggarwal. 2002. Transcription corepressor CtBP is an NAD(+)-regulated dehydrogenase. Mol. Cell 10:857–869.
  • Longo, L., O. C. Vanegas, M. Patel, V. Rosti, H. Li, J. Waka, T. Merghoub, P. P. Pandolfi, R. Notaro, K. Manova, and L. Luzzatto. 2002. Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J. 21:4229–4239.
  • Matsuda, M., I. Shimomura, M. Sata, Y. Arita, M. Nishida, N. Maeda, M. Kumada, Y. Okamoto, H. Nagaretani, H. Nishizawa, K. Kishida, R. Komuro, N. Ouchi, S. Kihara, R. Nagai, T. Funahashi, and Y. Matsuzawa. 2002. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem. 277:37487–37491.
  • Matsuzawa, Y., T. Funahashi, S. Kihara, and I. Shimomura. 2004. Adiponectin and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 24:29–33.
  • Matsuzawa, Y., T. Funahashi, and T. Nakamura. 1999. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann. N. Y. Acad. Sci. 892:146–154.
  • Mohamed-Ali, V., J. H. Pinkney, and S. W. Coppack. 1998. Adipose tissue as an endocrine and paracrine organ. Int. J. Obesity Relat. Metab. Disorders 22:1145–1158.
  • Moitra, J., M. M. Mason, M. Olive, D. Krylov, O. Gavrilova, B. Marcus-Samuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, M. L. Reitman, and C. Vinson. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12:3168–3181.
  • Nadler, S. T., and A. D. Attie. 2001. Please pass the chips: genomic insights into obesity and diabetes. J. Nutr. 131:2078–2081.
  • Nadler, S. T., J. P. Stoehr, K. L. Schueler, G. Tanimoto, B. S. Yandell, and A. D. Attie. 2000. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc. Natl. Acad. Sci. USA 97:11371–11376.
  • Naylor, C. E., P. Rowland, A. K. Basak, S. Gover, P. J. Mason, J. M. Bautista, T. J. Vulliamy, L. Luzzatto, and M. J. Adams. 1996. Glucose 6-phosphate dehydrogenase mutations causing enzyme deficiency in a model of the tertiary structure of the human enzyme. Blood 87:2974–2982.
  • Okamoto, Y., S. Kihara, N. Ouchi, M. Nishida, Y. Arita, M. Kumada, K. Ohashi, N. Sakai, I. Shimomura, H. Kobayashi, N. Terasaka, T. Inaba, T. Funahashi, and Y. Matsuzawa. 2002. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106:2767–2770.
  • Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
  • Rajala, M. W., and P. E. Scherer. 2003. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765–3773.
  • Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14:1293–1307.
  • Ruan, H., and H. F. Lodish. 2003. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 14:447–455.
  • Ruderman, N., and M. Prentki. 2004. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat. Rev. Drug Discov. 3:340–351.
  • Ruderman, N. B., A. K. Saha, and E. W. Kraegen. 2003. Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144:5166–5171.
  • Salati, L. M., and B. Amir-Ahmady. 2001. Dietary regulation of expression of glucose-6-phosphate dehydrogenase. Annu. Rev. Nutr. 21:121–140.
  • Saltiel, A. R. 2001. You are what you secrete. Nat. Med. 7:887–888.
  • Shantz, L. M., P. Talalay, and G. B. Gordon. 1989. Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA 86:3852–3856.
  • Shimomura, I., Y. Bashmakov, and J. D. Horton. 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274:30028–30032.
  • Shimomura, I., R. E. Hammer, J. A. Richardson, S. Ikemoto, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 1998. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12:3182–3194.
  • Soukas, A., P. Cohen, N. D. Socci, and J. M. Friedman. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev. 14:963–980.
  • Spiegelman, B. M., and J. S. Flier. 1996. Adipogenesis and obesity: rounding out the big picture. Cell 87:377–389.
  • Spiegelman, B. M., and J. S. Flier. 2001. Obesity and the regulation of energy balance. Cell 104:531–543.
  • Stephens, J. M., J. Lee, and P. F. Pilch. 1997. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272:971–976.
  • Steppan, C. M., S. T. Bailey, S. Bhat, E. J. Brown, R. R. Banerjee, C. M. Wright, H. R. Patel, R. S. Ahima, and M. A. Lazar. 2001. The hormone resistin links obesity to diabetes. Nature 409:307–312.
  • Tian, W. N., L. D. Braunstein, J. Pang, K. M. Stuhlmeier, Q. C. Xi, X. Tian, and R. C. Stanton. 1998. Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J. Biol. Chem. 273:10609–10617.
  • Towle, H. C., E. N. Kaytor, and H. M. Shih. 1997. Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu. Rev. Nutr. 17:405–433.
  • Unger, R. H. 2004. The hyperleptinemia of obesity-regulator of caloric surpluses. Cell 117:145–146.
  • Unger, R. H. 2003. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144:5159–5165.
  • Wellen, K. E., and G. S. Hotamisligil. 2003. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Investig. 112:1785–1788.
  • Yamauchi, T., J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B. B. Kahn, and T. Kadowaki. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8:1288–1295.
  • Yamauchi, T., J. Kamon, H. Waki, Y. Imai, N. Shimozawa, K. Hioki, S. Uchida, Y. Ito, K. Takakuwa, J. Matsui, M. Takata, K. Eto, Y. Terauchi, K. Komeda, M. Tsunoda, K. Murakami, Y. Ohnishi, T. Naitoh, K. Yamamura, Y. Ueyama, P. Froguel, S. Kimura, R. Nagai, and T. Kadowaki. 2003. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 278:2461–2468.
  • Zhang, Q., D. W. Piston, and R. H. Goodman. 2002. Regulation of corepressor function by nuclear NADH. Science 295:1895–1897.
  • Zimmet, P., K. G. Alberti, and J. Shaw. 2001. Global and societal implications of the diabetes epidemic. Nature 414:782–787.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.